15 results on '"Appella E"'
Search Results
2. PML enhances the regulation of p53 by CK1 in response to DNA damage
- Author
-
Alsheich-Bartok, O, Haupt, S, Alkalay-Snir, I, Saito, S, Appella, E, and Haupt, Y
- Published
- 2008
- Full Text
- View/download PDF
3. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth
- Author
-
Migliaccio, A, Varricchio, L, De Falco, A, Castoria, G, Arra, C, Yamaguchi, H, Ciociola, A, Lombardi, M, Di Stasio, R, Barbieri, A, Baldi, A, Barone, M V, Appella, E, and Auricchio, F
- Published
- 2007
- Full Text
- View/download PDF
4. The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis
- Author
-
Demidov, O N, Kek, C, Shreeram, S, Timofeev, O, Fornace, A J, Appella, E, and Bulavin, D V
- Published
- 2007
- Full Text
- View/download PDF
5. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities
- Author
-
Fiscella, M., Nicola Zambrano, Ullrich, S. J., Unger, T., Lin, D., Cho, B., Mercer, W. E., Anderson, C. W., Appella, E., Fiscella, M, Zambrano, Nicola, Ullrich, Sj, Unger, T, Lin, D, Cho, B, Mercer, We, Anderson, Cw, and Appella, E.
- Subjects
Cyclin-Dependent Kinase Inhibitor p21 ,Transcriptional Activation ,Binding Sites ,Base Sequence ,Cell Cycle ,Molecular Sequence Data ,Nuclear Proteins ,Proto-Oncogene Proteins c-mdm2 ,DNA ,Protein Serine-Threonine Kinases ,Rats, Inbred F344 ,Neoplasm Proteins ,Rats ,Genes, ras ,Cyclins ,Proto-Oncogene Proteins ,Serine ,Tumor Cells, Cultured ,Animals ,Humans ,Adenovirus E1A Proteins ,Phosphorylation ,Tumor Suppressor Protein p53 ,Casein Kinase II ,Protein Kinase Inhibitors - Abstract
Wild-type p53 functions in the G1 DNA damage checkpoint pathway by activating gene transcription and preventing cell cycle progression. Others reported that mutation of the serine 386 codon in mouse p53 abolished its ability to suppress growth. Serine 386 of murine p53 and the homologous residue of human p53, serine 392, are phosphorylated in vivo and can be phosphorylated in vitro by casein kinase II (CKII). We constructed mutants that changed serine 392 of human p53 to alanine (p53-S392A) or aspartic acid (p53-S392D); cotransfection of both these mutants with a reporter gene carrying a p53-responsive element into the p53-null Saos-2 cell line activated transcription as well as did wild-type p53. Furthermore, both mutants blocked cell cycle progression after transient transfection in these cells. A stable derivative of the T98G human glioblastoma cell line was established that expressed p53-S392A in response to dexamethasone. Overexpression of this mutant activated transcription of the endogenous waf1 (also called cip1) and mdm2 genes to the same extent as wild-type p53 and also produced growth arrest. Finally, p53-S392A and p53-S392D suppressed foci formation by activated ras and adenovirus E1A oncogenes as efficiently as did wild-type p53. Thus, unlike mutants that altered the serine 15 phosphorylation site, elimination of the serine 392 phosphorylation site had no discernible effect on p53 function. We conclude that neither phosphorylation nor RNA attachment to serine 392 are required for human p53's ability to suppress cell growth or to activate transcription in vivo.
- Published
- 1994
6. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression
- Author
-
Fiscella M, Ullrich SJ, Shields MT, Lin D, Lees Miller SP, Anderson CW, Mercer WE, Appella E., ZAMBRANO, NICOLA, Fiscella, M, Ullrich, Sj, Zambrano, Nicola, Shields, Mt, Lin, D, Lees Miller, Sp, Anderson, Cw, Mercer, We, and Appella, E.
- Subjects
Base Sequence ,Cell Cycle ,Immunoblotting ,Molecular Sequence Data ,Antibodies, Monoclonal ,Blotting, Northern ,Genes, p53 ,Transfection ,Polymerase Chain Reaction ,Cell Line ,Kinetics ,Oligodeoxyribonucleotides ,Mutagenesis, Site-Directed ,Serine ,Humans ,Amino Acid Sequence ,RNA, Messenger ,Phosphorylation ,Tumor Suppressor Protein p53 ,Peptides ,Protein Kinases - Abstract
Overexpression of wild-type p53 prevents cells from entering the S phase of the cell cycle. The amino-terminal transactivation region of p53 is phosphorylated by several protein kinases, including DNA-PK, a nuclear serine/threonine protein kinase that in vitro requires DNA for activity. DNA-PK was recently shown to phosphorylate serines 15 and 37 of human p53 (Lees-Miller et al., 1992. Mol. Cell. Biol., 12, 5041-5049). To prevent phosphorylation at these sites, mutants were constructed that changed the codons for serine 15 or serine 37 to alanine codons. Expression of p53-Ala-37 in stably transformed T98G cells blocked progression of the cells into S phase as well as did the expression of wild-type p53. In contrast, p53-Ala-15 was partially defective in blocking cell cycle progression. Several cell clones transformed with the mutant p53-Ala-15 gene expressed normal levels of p53 mRNA but accumulated little or no detectable p53 protein. However, by using a transient expression system driven by a strong cytomegalovirus promoter, we showed that the inability of p53-Ala-15 to fully block cell cycle progression was not due to inadequate levels of expression or to a failure of the mutant protein to accumulate in the nucleus. These results suggest that phosphorylation of Ser-15 may affect p53 function.
- Published
- 1993
7. The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis
- Author
-
Lu, X, primary, Mazur, S J, additional, Lin, T, additional, Appella, E, additional, and Xu, Y, additional
- Published
- 2013
- Full Text
- View/download PDF
8. The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis
- Author
-
Demidov, O N, primary, Kek, C, additional, Shreeram, S, additional, Timofeev, O, additional, Fornace, A J, additional, Appella, E, additional, and Bulavin, D V, additional
- Published
- 2006
- Full Text
- View/download PDF
9. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth
- Author
-
Gabriella Castoria, Lilian Varricchio, R Di Stasio, Alfonso Baldi, Maria Vittoria Barone, Maria Lombardi, Ettore Appella, A. de Falco, Ferdinando Auricchio, Claudio Arra, Antonio Barbieri, Anna Rita Migliaccio, Hiroshi Yamaguchi, Alessandra Ciociola, Migliaccio, A, Varricchio, L, De Falco, A, Castoria, G, Arra, C, Yamaguchi, H, Ciociola, A, Lombardi, M, Di Stasio, R, Barbieri, A, Baldi, A, Barone, MARIA VITTORIA, Appella, E, Auricchio, F., Migliaccio, Antimo, DE FALCO, Antonietta, Castoria, Gabriella, DI STASIO, R, Baldi, Alfonso, and Barone, Mv
- Subjects
MAPK/ERK pathway ,Male ,Cancer Research ,Proto-Oncogene Proteins pp60(c-src) ,Breast Neoplasms ,Receptors, Estradiol ,Biology ,SH3 domain ,src Homology Domains ,Prostate cancer ,Mice ,Epidermal growth factor ,LNCaP ,Genetics ,medicine ,Androgen Receptor Antagonists ,Tumor Cells, Cultured ,Estrogen receptor ,Animals ,Humans ,Amino Acid Sequence ,Molecular Biology ,Xenograft ,Receptor antagonist ,Prostatic Neoplasms ,medicine.disease ,Androgen receptor ,Receptors, Androgen ,Cancer research ,Peptides ,Proto-oncogene tyrosine-protein kinase Src ,Src ,Protein Binding ,Signal Transduction - Abstract
In human mammary and prostate cancer cells, steroid hormones or epidermal growth factor (EGF) trigger association of the androgen receptor (AR)-estradiol receptor (ER) (α or β) complex with Src. This interaction activates Src and affects the G1 to S cell cycle progression. In this report, we identify the sequence responsible for the AR/Src interaction and describe a 10 amino-acid peptide that inhibits this interaction. Treatment of the human prostate or mammary cancer cells (LNCaP or MCF-7, respectively) with nanomolar concentrations of this peptide inhibits the androgen- or estradiol-induced association between the AR or the ER and Src the Src/Erk pathway activation, cyclin D1 expression and DNA synthesis, without interfering in the receptor-dependent transcriptional activity. Similarly, the peptide prevents the S phase entry of LNCaP and MCF-7 cells treated with EGF as well as mouse embryo fibroblasts stimulated with androgen or EGF. Interestingly, the peptide does not inhibit the S phase entry and cytoskeletal changes induced by EGF or serum treatment of AR-negative prostate cancer cell lines. The peptide is the first example of a specific inhibitor of steroid receptor-dependent signal transducing activity. The importance of these results is highlighted by the finding that the peptide strongly inhibits the growth of LNCaP xenografts established in nude mice. © 2007 Nature Publishing Group All rights reserved.
- Published
- 2007
10. The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation.
- Author
-
Fazioli F, Wong WT, Ullrich SJ, Sakaguchi K, Appella E, and Di Fiore PP
- Subjects
- Amino Acid Sequence, Animals, Antigens, Neoplasm analysis, Base Sequence, Blood Proteins genetics, Blood Proteins metabolism, Cloning, Molecular, ErbB Receptors metabolism, Histocompatibility Antigens analysis, Humans, Membrane Proteins genetics, Membrane Proteins metabolism, Mice, Molecular Sequence Data, Phosphoproteins analysis, Phosphorylation, Proteins metabolism, Rabbits, Receptors, Platelet-Derived Growth Factor metabolism, Cell Transformation, Neoplastic, Cytoskeletal Proteins, Microfilament Proteins, Neuropeptides, Phosphoproteins metabolism, Protein-Tyrosine Kinases metabolism, Tyrosine metabolism
- Abstract
A method for the isolation of tyrosine kinases substrates was developed. The method takes advantage of immuno-affinity purification of an entire set of proteins phosphorylated by tyrosine kinases, followed by generation of antisera against the purified protein pool and immunological screening of bacterial expression libraries with these antisera. By applying this methodology to the study of the phosphorylation events triggered by activation of the epidermal growth factor receptors, we have isolated several cDNAs encoding novel putative tyrosine kinase substrates. One of these cDNAs encodes radixin, a protein belonging to the band 4.1 family of proteins and highly related to ezrin and moesin. We demonstrated that, despite a high degree of relatedness, these three proteins exhibit a distinct receptor-specific pattern of phosphorylation, raising the possibility that they might mediate receptor-specific cellular changes. In addition the generation of antibodies specific for either radixin, ezrin or moesin allowed us to show that a previously described tumor transplantation antigen is indeed ezrin, thus implicating this protein in the determination of the biological phenotype of certain tumors.
- Published
- 1993
11. p53 mutations in Raji cells: characterization and localization relative to other Burkitt's lymphomas.
- Author
-
Duthu A, Debuire B, Romano J, Ehrhart JC, Fiscella M, May E, Appella E, and May P
- Subjects
- Alleles, Amino Acid Sequence, Base Sequence, Cell Line, Humans, Molecular Sequence Data, Burkitt Lymphoma genetics, Genes, p53, Mutation
- Abstract
The nuclear phosphoprotein p53 is an important regulator of cell proliferation in normal cells. Interestingly, the gene encoding p53 has usually undergone mutations in a wide range of tumor types. Recent studies of the p53 gene in Burkitt's lymphomas have demonstrated that mutations are extremely common, and in fact it is rare that both alleles of the p53 gene in these tumors are not inactivated by mutation or deletion. We present here genetic data regarding the status of the p53 gene in the Burkitt lymphoma cell line, Raji. As is typical for this type of tumor, both alleles have undergone point mutations. Further, statistical analysis of available data from a large number of Burkitt's lymphomas indicates an apparent tumor-specific distribution of p53 mutations. The possibility that specific mutations of the p53 gene may be important for different tumor types is discussed.
- Published
- 1992
12. Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells.
- Author
-
Ullrich SJ, Mercer WE, and Appella E
- Subjects
- Base Sequence, Electrophoresis, Gel, Two-Dimensional, G1 Phase physiology, Glioma genetics, Humans, Molecular Sequence Data, Mutation genetics, Oligodeoxyribonucleotides genetics, Phosphorylation, Polymerase Chain Reaction, Precipitin Tests, Protein Conformation, Tumor Cells, Cultured, Tumor Suppressor Protein p53 chemistry, Tumor Suppressor Protein p53 genetics, Glioma metabolism, Tumor Suppressor Protein p53 metabolism
- Abstract
The wild-type (wt) human tumor-suppressor gene product, p53, and its mutant form have been analysed in an in vivo system in which the inducible expression of wt p53 results in growth arrest in the G1 phase of the cell cycle. Two major pools of p53 are detected after wt p53 expression by their differential reactivity with the p53 monoclonal antibodies PAb 421 and 1801 as well as the mutant and wt-specific monoclonal antibodies PAb 240 and 1620; one pool contains wt and mutant p53 and is characterized as having a mutant conformation, whereas the other pool contains only wt p53 with a wt conformation. As G1 arrest is entered, the amount of wt p53 associated with the mutant pool decreases, such that by 12 h free wt and mutant p53 are the major pools. Two-dimensional gel analysis of the p53 pools revealed that free wt p53 is phosphorylated to a greater degree than mutant p53, which correlated with the loss of the PAb 421 epitope on wt p53. In summary, the ability of wt p53 to exert an antiproliferative effect correlates with the presence of a unique conformational state of wt p53 characterized by increased phosphorylation and the loss of both the PAb 421 epitope and association with mutant p53 pool, whereas mutant p53 is unable to assume this conformational state.
- Published
- 1992
13. Wild type human p53 is antiproliferative in SV40-transformed hamster cells.
- Author
-
Mercer WE, Amin M, Sauve GJ, Appella E, Ullrich SJ, and Romano JW
- Subjects
- Blotting, Northern, Cell Line, Cell Transformation, Viral, Gene Expression, Humans, Simian virus 40, Transfection, Tumor Suppressor Protein p53, Cell Division, Oncogene Proteins physiology, Phosphoproteins physiology
- Abstract
The transformation related protein p53 has been implicated in the process of normal cell proliferation and neoplastic transformation. In this study, the influence of wild type human p53 on cell proliferation was examined. Plasmid constructs encoding the wild type human p53 and various mutant p53 cDNAs, driven by the mouse mammary tumor virus (MMTV) promoter linked to the dominant biochemical selection marker gpt, were used in a colony forming assay employing SV40 transformed HR8 hamster cells. Plasmids encoding wild type p53 drastically reduced the number of gpt+ colonies obtained after transfection, whereas the mutant forms of p53 had no effect. Stable clonal hamster cell lines that constitutively express wild type p53 were isolated and found to have altered growth characteristics (i.e. lower saturation densities, increased doubling times). These findings are consistent with the notion that wild type p53 protein could function as a growth suppressor. The potential role of p53 in the normal cell cycle and in the transformation process is discussed.
- Published
- 1990
14. Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.
- Author
-
Romano JW, Ehrhart JC, Duthu A, Kim CM, Appella E, and May P
- Subjects
- Base Sequence, Cell Line, Cloning, Molecular, DNA, Neoplasm genetics, Half-Life, Humans, Molecular Sequence Data, Oligonucleotide Probes, Oncogene Proteins metabolism, Phosphoproteins metabolism, Tumor Suppressor Protein p53, Genes, Mutation, Nuclear Proteins genetics, Oncogene Proteins genetics, Osteosarcoma genetics, Phosphoproteins genetics
- Abstract
The nuclear phosphoprotein p53 occurs at elevated levels in many transformed cells. Mutant forms of mouse p53 possess enhanced transforming activity compared with wild type p53. Mutant mouse p53 proteins form complexes with the 70 kDa family of heat shock proteins (HSPs). We previously demonstrated an association between p53 and the 70 kDa HSPs in the human osteosarcoma (HOS) derived cell line HOS-SL. We report here the molecular cloning and sequencing of the p53 gene from HOS-SL cells, and demonstrate that it is in fact mutant. Further, analysis of similar HOS-derived cell lines demonstrates that they also encode the same mutant form of p53, whereas the wild type form of p53 appears to be lost in these cells. Stability studies demonstrate an increased half life of the p53 protein in these cells, in keeping with its association with the HSP 70 proteins. A potential role for this p53 mutant in the transformation process is discussed.
- Published
- 1989
15. Specific interaction between a subset of the p53 protein family and heat shock proteins hsp72/hsc73 in a human osteosarcoma cell line.
- Author
-
Ehrhart JC, Duthu A, Ullrich S, Appella E, and May P
- Subjects
- Antibodies, Monoclonal, Cell Line, Electrophoresis, Gel, Two-Dimensional, Electrophoresis, Polyacrylamide Gel, Heat-Shock Proteins isolation & purification, Humans, Immune Sera, Kinetics, Molecular Weight, Oncogene Proteins isolation & purification, Osteosarcoma, Phosphoproteins isolation & purification, Tumor Suppressor Protein p53, Heat-Shock Proteins metabolism, Nuclear Proteins metabolism, Oncogene Proteins metabolism, Phosphoproteins metabolism, Tumor Cells, Cultured metabolism
- Abstract
We report here immunological evidence for the specific association between p53 and hsp72/hsc73 heat shock proteins in a human cell line derived from an osteosarcoma. The same association between p53 and hsp72/hsc73 was observed in HOS-TE85 clone 5 from which the HOS-SL cell line was derived. This association was indicated by the co-immunoprecipitation from HOS-SL of both p53 and hsp72/hsc73 proteins observed with either an anti-p53 monoclonal antibody (PAb421) or an antiserum specifically reacting with hsp72/hsc73 heat shock proteins. Furthermore, Western blot analysis allowed us to show that hsp72/hsc73 proteins did not share an epitope with p53, confirming that the co-immunoprecipitation of p53 and hsp72/hsc73 was attributable to the physical association of the proteins. Data obtained from SDS-PAGE show that the HOS-SL cells expressed two forms of p53 with distinct molecular weights. Both forms contained several species with different isoelectric points ranging between pH 6.0 and 6.5. The data obtained from both 1D and 2D gel analyses consistently show that the p53 proteins involved in the association with hsp72/hsc73 were mainly the species that migrated with the slower mobility in the SDS dimension. The possibility is discussed that the HOS-SL p53 variant forming a complex with hsp72/hsc73 contains an activating mutation for transformation.
- Published
- 1988
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.